According to Evaluate, Lillys retatrutide (GLP-1/GIP/glucagon) hit 2324% in Phase 2, with 2030 sales modeled around $5.6B
En algunos casos, los clientes quedan satisfechos con los resultados tras una sola sesin
Although initial studies look promising, there isnt a ton of robust, evidence-based data on glycine benefits to back up the claims
Brown SD, Nativo P, Smith J-A et al (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin
Researchers also compare GHK-Cu with investigational peptides including KPV, TB-500, BPC-157, Epitalon , and MOTS-c to better understand molecular characteristics, formulation behavior, peptide stability, and laboratory applications
J Cancer Metastasis Treat 2019;5(1)